Suppr超能文献

[散光型人工晶状体植入5年以上的安全性和有效性]

[Safety and efficacy of toric intraocular lens implantation for more than 5 years].

作者信息

Song X D, Hao Y S, Bao Y Z, Li Z H, Zhang H, Yu A Y, Zhao M S, Huang Y S, Fang J, Liu Y, Sun Y X, Wang N L

机构信息

Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Ophthalmology, Beijing Key Laboratory of Ophthalmology & Visual Sciences, Beijing 100730, China.

Department of Ophthalmology, Peking University Third Hospital, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Beijing 100191, China.

出版信息

Zhonghua Yan Ke Za Zhi. 2023 Feb 11;59(2):118-128. doi: 10.3760/cma.j.cn112142-20220826-00417.

Abstract

To evaluate the clinical safety and efficacy of toric intraocular lens (IOL) implantation for more than 5 years. This study was a prospective cohort study in which subjects were continuously observed over a two-year period (May 2014 to May 2016) in nine hospitals. The study randomly assigned subjects to two groups using a central dynamic randomization system: the study group, which received Proming IQ toric IOL implants, and the control group, which received AcrySof IQ toric IOL implants. The subjects completed a one-year follow-up, during which various measures were taken and evaluated, including visual acuity, IOL rotation, postoperative complications, intraocular pressure, and subjective evaluation (preoperatively and at 1 day, 6 months, 1 year, and 5 years post-surgery). The main statistical analysis methods include the Mann-Whitney test, independent sample -test, Wilcoxon signed rank test, paired sample -test, chi-square test, and Fisher's exact test. A total of 45 eyes (26 in the study group and 19 in the control group) completed the five-year continuous observation period. The mean age of the subjects was (72.07±10.67) years and the mean interval from surgery to the last visit was (5.39±0.47) years. After five years, there were no significant differences in uncorrected distance visual acuity (0.20±0.26 . 0.16±0.13, 0.17,0.752), best corrected distance visual acuity[0.00(0.00, 0.20) 0.05±0.10, 188.00, 0.880], uncorrected near visual acuity[0.50 (0.20, 0.60) 0.42±0.20, 0.35, =0.857], and best corrected near visual acuity (0.13±0.16 0.17±0.23, 161.00, =0.884) between the two groups. However, all measures improved significantly from baseline levels in both groups (all 0.05). Five years after surgery, no matter objective refraction [(-0.67±0.85) D (-0.73±1.08)D] or subjective refraction[-0.50 (-1.00, 0.00)D (0.69±0.87)D], the degree of cylindrical degree is significantly lower than preoperative corneal astigmatism [(1.27±0.49) D (1.34±0.82) D, all 0.001]. In addition, there were no significant differences in intraocular pressure, subjective evaluation of visual adverse symptoms, distance vision spectacle independence, or overall satisfaction evaluation between the two groups (all 0.05). The IOL rotation was 3.0°(1.0°, 6.0°) in the study group and 4.0°(2.0°, 6.0°)in the control group (=185.50,0.574), indicating no significant difference between the groups in terms of rotational stability. Five years after surgery, there were 7 cases of posterior capsular opacification in the study group and 4 cases in the control group. There were no cases of IOL glistening in the study group, but 5 cases (26.32%) were observed in the control group. The long-term effects of Proming toric IOL implantation in correcting cataracts with regular corneal astigmatism are clear after five years, with few complications and stable results.

摘要

评估 toric 人工晶状体(IOL)植入超过 5 年的临床安全性和有效性。本研究为前瞻性队列研究,在 9 家医院对受试者进行了为期两年(2014 年 5 月至 2016 年 5 月)的连续观察。该研究使用中央动态随机化系统将受试者随机分为两组:研究组接受 Proming IQ toric IOL 植入,对照组接受 AcrySof IQ toric IOL 植入。受试者完成了为期一年的随访,在此期间采取并评估了各种指标,包括视力、IOL 旋转、术后并发症、眼压以及主观评估(术前以及术后 1 天、6 个月、1 年和 5 年)。主要统计分析方法包括 Mann-Whitney 检验、独立样本 t 检验、Wilcoxon 符号秩检验、配对样本 t 检验、卡方检验和 Fisher 精确检验。共有 45 只眼(研究组 26 只,对照组 19 只)完成了五年的连续观察期。受试者的平均年龄为(72.07±10.67)岁,手术至最后一次随访的平均间隔时间为(5.39±0.47)年。五年后,两组间未矫正远视力(0.20±0.26. 0.16±0.13,0.17,0.752)、最佳矫正远视力[(0.00(0.00,0.20) 0.05±0.10,188.00,0.880]、未矫正近视力[0.50(0.20,0.60) 0.42±0.20,0.35,=0.857]和最佳矫正近视力(0.13±0.16 0.17±0.23,161.00,=0.884)均无显著差异。然而,两组所有指标均较基线水平有显著改善(均 P<0.05)。术后五年,无论客观验光[(-0.67±0.85)D (-0.73±1.08)D]还是主观验光[-0.50(-1.00,0.00)D (0.69±0.87)D],柱镜度数均显著低于术前角膜散光[(1.27±0.49)D (1.34±0.82)D,均 P<0.001]。此外,两组间眼压、视觉不良症状主观评估、远视力眼镜独立性或总体满意度评估均无显著差异(均 P>0.05)。研究组 IOL 旋转度数为 3.0°(1.0°,6.0°),对照组为 4.0°(2.0°,6.0°)(=185.50,0.574),表明两组在旋转稳定性方面无显著差异。术后五年,研究组有 7 例后囊膜混浊,对照组有 4 例。研究组未观察到 IOL 闪烁病例,但对照组观察到 5 例(26.32%)。Proming toric IOL 植入矫正规则角膜散光性白内障的长期效果在五年后明确,并发症少,结果稳定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验